Lanatoside C

Lanatoside C is a cardiac glycoside used mainly for heart conditions like congestive heart failure and arrhythmias (e.g., atrial fibrillation, supraventricular tachycardia) by affecting ion pumps in heart cells, but it also shows promising anti-cancer potential by inducing cancer cell death and inhibiting proliferation, with research exploring its use against various cancers and even viral infections like Dengue and Herpes. It is grouped under the following drug class(es): Glycosides. The directory classifies it as a discontinued API with a natural source/manufacturing origin. Other names for this substance include Isolanid and Cedilanid. Its PubChem CID is 656630.

CAS No 17575-22-3
Molecular Formula C49H76O20
Molecular Weight 985.1 g/mol
Synonyms [(2R,3R,4S,6S)-6-[(2R,3S,4S,6S)-6-[(2R,3S,4S,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl] acetate

Frequently Asked Questions